NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 100 filers reported holding NUVALENT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $164,446,964 | +9.0% | 3,577,267 | 0.0% | 18.39% | +18.4% |
Q2 2023 | $150,853,349 | +161532.6% | 3,577,267 | 0.0% | 15.54% | +33.2% |
Q1 2023 | $93,331 | -12.4% | 3,577,267 | 0.0% | 11.66% | -2.0% |
Q4 2022 | $106,531 | -99.8% | 3,577,267 | +4.4% | 11.90% | +49.7% |
Q3 2022 | $66,641,000 | +43.4% | 3,428,014 | 0.0% | 7.96% | +45.9% |
Q2 2022 | $46,484,000 | -2.4% | 3,428,014 | 0.0% | 5.45% | +17.9% |
Q1 2022 | $47,615,000 | -27.0% | 3,428,014 | 0.0% | 4.62% | -10.6% |
Q4 2021 | $65,269,000 | -15.6% | 3,428,014 | 0.0% | 5.18% | +7.9% |
Q3 2021 | $77,302,000 | – | 3,428,014 | – | 4.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |